ferric carboxymaltose: Clinical Trials

180 trials of ferric carboxymaltose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

104 completed, 35 unknown, 18 terminated, 10 recruiting. 72 Phase 4, 57 Phase 3, 21 Phase 2, 18 Not applicable, 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 472Completed 29, Unknown 21, Terminated 10, Recruiting 6, Not yet recruiting 4, Withdrawn 2
Phase 357Completed 44, Terminated 4, Unknown 3, Not yet recruiting 2, Recruiting 2, Withdrawn 2
Phase 221Completed 11, Terminated 5, Unknown 3, Not yet recruiting 1, Withdrawn 1
Not applicable18Completed 13, Unknown 4, Recruiting 1
Phase 16Completed 4, Recruiting 1, Withdrawn 1

Follow ferric carboxymaltose: new trials by email Literature Review of ferric carboxymaltose trials Research Report on ferric carboxymaltose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test the Non-Inferiority of Ferric Bepectate IV Against Ferric Carboxymaltose in Patients With Iron Deficiency Anemia
Ferric Bepectate IV Injection, Ferric Carboxymaltose Injection [Ferinject], Ferric Carboxymaltose Injection [Injectafer®] - Iron Deficiency Anemia (IDA)
Phase 3Not yet recruitingAFT Pharmaceuticals, Ltd.13662026-12-012026-08-20
Intravenous Iron in the Management of Drug-resistant Restless Legs syndromeI
Ferric Carboxymaltose Injection [Ferinject], Randomization, Questionnaire and Physical Exam - Restless Legs Syndrome (RLS)
Phase 2Not yet recruitingUniversity Hospital, Montpellier662026-10-012026-09-16
Ferric Carboxymaltose Versus Iron Sucrose for Iron Deficiency Anemia After Radical Gastrectomy for Gastric Cancer
Ferric Carboxymaltose (FCM), Iron Sucrose. - Gastric Cancer (GC), Iron Deficiency Anemia (IDA)
Phase 4Not yet recruitingZhaojian Niu,MD1602026-08-012026-08-19
Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants Under Fasting Conditions
Ferric Carboxymaltose Injection, Ferric Carboxymaltose Injection [Injectafer®] - Healthy Adult
Phase 1RecruitingSichuan Huiyu Pharmaceutical Co., Ltd702026-05-192026-10-13
Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome
Ferric Carboxymaltose Injection [Ferinject] - Acute Coronary Syndromes (ACS), Iron Deficiencies
Phase 4RecruitingFundación para la Investigación del Hospital Clínico de Valencia5382026-03-052026-03-24
The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department
Ferric Carboxymaltose (FCM), Ferrous Sulfate - Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease, Iron Deficiency Anaemia Due to Dietary Causes
Phase 4Not yet recruitingChildren's Hospital of Orange County1502026-01-312026-02-17
The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension
Ferric Carboxymaltose (FCM), Sodium Chloride (NaCl) 0.9 % - Pulmonary Hypertension, Iron Deficiency
Phase 4RecruitingZiekenhuis Oost-Limburg3062026-01-272026-01-30
The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the Elderly
Ferric carboxymaltose - Ferric Carboxymaltose
Not applicableRecruitingXuanwu Hospital, Beijing1002025-07-012025-07-10
EFFICACY OF IV VERSUS ORAL IRON IN THE TREATMENT OF IRON DEFICIENCY ANEMIA DURING PREGNANCY
Iron Carboxymaltose, Iron Polymaltose Complex - Iron Deficiency Anaemia in Childbirth
Phase 1CompletedDr Salaha Azam1122025-06-012026-02-03
Ferric Carboxymaltose Methemoglobinemia Study
Ferric Carboxymaltose (FCM) - Methemoglobinemia, Anemia, Iron-Deficiency
CompletedOrdu University9772025-04-142025-11-19
Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants
Ferric Carboxymaltose Injection, Ferric Carboxymaltose Injection [Injectafer®] - Healthy Adult
Phase 1CompletedSichuan Huiyu Pharmaceutical Co., Ltd842025-04-072025-05-18
IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
Ferric Carboxymaltose, Ferrous Sulfate - Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF)
Phase 4TerminatedSyed Hamza Mufarrih422025-04-022026-07-20
Efficacy of Ferric Carboxymaltose Versus Iron Sucrose in Non-dialysis Dependent Chronic Kidney Disease Patients
Ferric Carboxymaltose (FCM), Iron Sucrose injection - Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
Not applicableCompletedSindh Institute of Urology and Transplantation1282025-04-012026-04-22
Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
Ferric carboxymaltose, Placebo - Surgery, Liver Metastases
Phase 3RecruitingJon Unosson3382024-09-042024-10-21
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
Iron Carboxymaltose, Dapagliflozin 10mg Tab, Placebo of Iron Carboxymaltose - Heart Failure, Systolic, Iron Deficiencies
Phase 3Not yet recruitingHospital de Clinicas de Porto Alegre992024-05-242024-06-03
IV Iron-induced Hypophosphatemia After RYGB
Iron isomaltoside, Iron Carboxymaltose - Hypophosphatemia, Roux-en-Y Gastric Bypass
Phase 4UnknownLucie Favre942024-05-022024-08-20
Comparative Analysis of Oral Iron With Injectable Ferric Carboxymaltose for Post Partum Iron Deficiency Anaemia
Ferric Carboxymaltose (FCM) - Anemia, Anemia, Postpartum
Phase 2 / Phase 3CompletedESI-PGIMSR, Basaidarapur2002024-03-012026-06-15
Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women
Iron Carboxymaltose, Iron Sucrose Injection - Iron Deficiency Anemia (IDA), Pregnancy
Phase 4CompletedCMH Multan Institute of Medical Sciences602024-02-012025-04-06
Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure
IV Iron Infusion Group - Heart Failure, Iron-deficiency
Phase 4TerminatedRadha Gopalan62024-01-242026-07-29
Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency
Sucrosomial iron, Vitamin D, Ferric Carboxymaltose 50 MG/ML - Heart Failure, Iron-deficiency
Phase 4UnknownUniversity of Padova2582024-01-152023-12-15

Showing 20 of 180. Sign in to see all of them.

Conditions studied

Anemia, Iron-Deficiency (71)  ·  Anemia (61)  ·  Iron Deficiencies (47)  ·  Heart Failure (17)  ·  Restless Legs Syndrome (7)  ·  Heart Failure, Systolic (5)  ·  Inflammatory Bowel Diseases (5)  ·  Postoperative Complications (5)  ·  Colorectal Neoplasms (4)  ·  Fatigue (4)  ·  Neoplasms (4)  ·  Renal Insufficiency, Chronic (4)  ·  Colitis, Ulcerative (3)  ·  Crohn Disease (3)  ·  Hip Fractures (3)

Sponsors

American Regent, Inc. (28)  ·  Vifor Pharma (12)  ·  University of Zurich (4)  ·  Konkuk University Medical Center (3)  ·  Pharmacosmos A/S (3)  ·  Sichuan Huiyu Pharmaceutical Co., Ltd (3)  ·  Thomas Jefferson University (3)  ·  University Hospital, Montpellier (3)  ·  University of Oxford (3)  ·  Asan Medical Center (2)  ·  Fundación para la Investigación del Hospital Clínico de Valencia (2)  ·  Helsinki University Central Hospital (2)  ·  Hospital Universitari de Bellvitge (2)  ·  National Cancer Center, Korea (2)  ·  Nottingham University Hospitals NHS Trust (2)

Countries

United States (35)  ·  Germany (17)  ·  Spain (12)  ·  Switzerland (11)  ·  United Kingdom (11)  ·  Netherlands (10)  ·  France (9)  ·  Poland (9)  ·  South Korea (9)  ·  Austria (8)  ·  Italy (7)  ·  Russia (7)  ·  China (6)  ·  India (6)  ·  Pakistan (5)

Top investigators

Mark Falone, MD (5)  ·  Richard Derman, MD, MPH (3)  ·  Christoph Gasche, Professor (2)  ·  Mark A Falone, MD (2)  ·  Piotr Ponikowski, MD (2)  ·  Yong In, MD, PhD (2)  ·  Adrian F Hernandez, MD (1)  ·  Albina Nowak, MD (1)  ·  Ali Erol, MD (1)  ·  Alla A. Garganeeva, M.D. (1)  ·  Ana Apodaka Diez, MD (1)

Results publications

PMID 17666600, PMID 22353604, PMID 27195774, PMID 31036337, PMID 32016310, PMID 10029607, PMID 10924610, PMID 11910485, PMID 17330243, PMID 18567277, PMID 18752459, PMID 18928998, PMID 19682342, PMID 19875408, PMID 1990875, PMID 19920054, PMID 20124051, PMID 20466657, PMID 20929915, PMID 23078888, PMID 23505057, PMID 2354408, PMID 23963731, PMID 24251969, PMID 24708660, PMID 24751822, PMID 24780615, PMID 24891437, PMID 25176939, PMID 25928811, PMID 26041028, PMID 26123286, PMID 27140401, PMID 27624208, PMID 27793204, PMID 28095881, PMID 28339831, PMID 28487769, PMID 28535237, PMID 28701470, PMID 29134606, PMID 29149437, PMID 29607528, PMID 29747838, PMID 30051186, PMID 30518682, PMID 30528802, PMID 30853478, PMID 30981629, PMID 31668348

NIH funding

2016 (5), 2009 (2), 2018 (2), 2019 (2), 2008 (1), 2014 (1), 2015 (1), 2025 (1), P01AG021190 (1)